Skip to main content
SpringerLink
Log in

Nachsorge des Mammacarcinoms

  • Chapter
Mammacarcinom

Part of the book series: Onkologie heute ((ONKOLOGIE))

  • 24 Accesses

Zusammenfassung

Nach der Primärbehandlung einer Mammacarcinomerkrankung muß mindestens zehn Jahre lang, gelegentlich auch länger als zwanzig Jahre lang, mit einer erneuten Tumormanifestation gerechnet werden. Bei jenen Patientinnen, die zehn Jahre die Nachsorge wahrnehmen, wird innerhalb dieses Zeitraumes eine jährliche Metastasierungsrate von 5% bis 10% beobachtet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 39.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. ACOG Committee Opinion (1996) Tamoxifen and endometrium cancer: Committee opinion on gynecologic practice. J Am Coll of Obstetricians and Gynecologists: No. 169.

    Google Scholar 

  2. Baker RR, et al. (1977) An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer. Ann Surg 186(3): 363–368.

    Article  PubMed  CAS  Google Scholar 

  3. Bissett D, Davis JA, George WD (1994) Gynaecological monitoring during tamoxifen therapy. Lancet 344: 1244.

    Article  PubMed  CAS  Google Scholar 

  4. Broyn T, Froyen J (1982) Evaluation of routine follow-up after surgery for breast carcinoma. Acta Chir Scand 148(5): 401–404.

    PubMed  CAS  Google Scholar 

  5. Burkett FE, Scanion EF, Garces R, et al. (1979) The value of bone scans in the management of patients with carcinoma of the breast. Surg Gyncol Obstet 149(4): 523–525.

    CAS  Google Scholar 

  6. Ciatto S, et al. (1993) Cancer reoccurrence in the conserved breast: Diagnostic features in a consecutive series of 102 cases. Intl J Oncol 3: 337–339.

    CAS  Google Scholar 

  7. Corcoron RJ, et al. (1976) Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121: 663–667.

    Google Scholar 

  8. Crivellari D, et al. (1995) Routine tests during follow-up of patients after primary treatment for operable breast cancer. Ann Oncol 6(g): 769–776.

    PubMed  CAS  Google Scholar 

  9. Del Turco MR, et al. (1994) Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial: National Research Council Project on Breast Cancer Follow-Up. JAMA 271(20): 1593–1597.

    Article  Google Scholar 

  10. Dershaw DD, et al. (1992) Detection of local recurrence after conservative therapy for breast carcinoma. Cancer 70(2): 493–496.

    Article  PubMed  CAS  Google Scholar 

  11. Dewar JA, Kerr GR (1985) Value of routine follow up of women treated for early carcinoma of the breast. BMJ 291: 1464–1467.

    Article  PubMed  CAS  Google Scholar 

  12. Fisher B, et al. (1994) Endometrail cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP)B-14. J Natl Cancer Inst 86(7): 527–537.

    Article  PubMed  CAS  Google Scholar 

  13. Hassell PR, et al. (1990) Early breast cancer: Detection of recurrence after conservative surgery and radiation therapy. Radiology 176(3): 731–735.

    PubMed  CAS  Google Scholar 

  14. Hellriegel KP, Schulz HD (1995) Nachsorge bei Mammacarcinom-Patientinnen. Empfehlungen einer Consensus-Tagung, Berlin 23.-24. 02.1995. Onkologie 1: 405–412.

    Google Scholar 

  15. Hölzel D, et al. (1997) Nachsorge in Empfehlungen zur Diagnostik, Therapie und Nachsorge — Mammacarcinome, 6. Aufl., Nachdruck 1997. Schriftenreihe Tumorzentrum, München.

    Google Scholar 

  16. Jäger W, et al. (1995) Breast cancer and clinical utility of CA 15-3 and CEA. Scand J Clin Lab Invest 55(Suppl. 221): 87–92.

    Article  Google Scholar 

  17. Kovner F, et al. (1994) Treatment of disease negative but mucin-like carcinoma-associated antigen-positive breast cancer patients with tamoxifen: Preliminary results of a prospective randomized study. Cancer Chemoth Pharmacol 35: 80–83.

    Article  CAS  Google Scholar 

  18. McNeil BJ, et al. (1978) Pre-operative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gyncol Obstet 147(5): 745–748.

    CAS  Google Scholar 

  19. Mellink WA, et al. (1991) The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer 67(7): 1844–1848.

    Article  PubMed  CAS  Google Scholar 

  20. Muss HB, et al. (1988) Follow-up after stage II breast cancer: A comparative study of relapsed versus nonrelapsed patients. Am J Clin Oncol (CCT) 11(4): 451–455.

    Article  CAS  Google Scholar 

  21. O’Connell MJ, et al. (1978) Value of preoperative radionucleotide bone scans in suspected primary breast cancer. Mayo Clin Pro 53(4): 221–226.

    Google Scholar 

  22. Orel SG, et al. (1993) Breast cancer recurrence after lumpectomy and radiation therapy for early-stage disease: Prognostic significance of detection method. Radiology 188(1): 189–194.

    PubMed  CAS  Google Scholar 

  23. Orel SG, et al. (1992) Breast cancer recurrence after lumpectomy and irradiation: Role of mammography in detraction. Radiology 183(1): 201–206.

    PubMed  CAS  Google Scholar 

  24. Orniston MC, et al. (1985) Is follow-up of patients after surgery for breast cancer worthwhile? J R Soc Med 78: 920–921.

    Google Scholar 

  25. Pandya KJ, et al. (1985) A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group Adjuvant Chemotherapy Trials for breast cancer. A preliminary report. Cancer 55(1): 202–205.

    Article  PubMed  CAS  Google Scholar 

  26. Pedrazzini A, et al. (1986) First repeated bone scan in the observation of patients with operable breast cancer. J Clin Oncol 4(3): 389–394.

    PubMed  CAS  Google Scholar 

  27. Perez DJ, et al. (1983) Detection of breast carcinoma metastases in bone: Relative merits of x-rays and skeletal scinitigraphy. Lancet 2: 613–616.

    Article  PubMed  CAS  Google Scholar 

  28. Recommended Breast Cancer Surveillance Guidelines. Adopted on February 20, 1997 by the American Society for Clinical Oncology (ASCO). J Clin Oncol 15: 2147–2156.

    Google Scholar 

  29. Rossing N, et al. (1982) What do early bone scans tell about breast cancer patients? Eur J Cancer Clin Oncol 18: 629–636.

    Article  PubMed  CAS  Google Scholar 

  30. Sauer H (1996) Empfehlungen zur Diagnostik, Therapie und Nachsorge-Mammacarcinome. Schriftenreihe Tumorzentrum München, 6. Auflage, Nachdruck 1997.

    Google Scholar 

  31. Scanion EF, et al. (1980) Preoperative and follow-up procedures on patients with breast cancer. Cancer 46(Suppl. 4): 77–79.

    Google Scholar 

  32. Schapira DV, Urban N (1991) A minimalist policy for breast cancer surveillance. JAMA 265(3): 380–382.

    Article  PubMed  CAS  Google Scholar 

  33. Senofsky GM, et al. (1986) Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer? Cancer 57(3): 579–602.

    Article  Google Scholar 

  34. Sismondi P, et al. (1994) Tamoxifen and endometrial cancer. Am NY Acad Sci 734: 310–321.

    Article  CAS  Google Scholar 

  35. The GIVIO Investigators (1994) Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. JAMA 271(20): 1587–1592.

    Article  Google Scholar 

  36. Van Leeuwen FE, et al. (1994) Risk of endmetrial cancer after tamoxifen treatment of breast cancer. Lancet 343: 448–452.

    Article  PubMed  Google Scholar 

  37. Winchester DP, et al. (1979) Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 43(3): 956–960.

    Article  PubMed  CAS  Google Scholar 

  38. Zuziely B, et al. (1993) The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 26(1): 101–105.

    Article  Google Scholar 

  39. Zwaveling A, et al. (1987) An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol 34(3): 194–197.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Abteilung für Onkologie, Medizinische Universitätsklinik, Auenbruggerplatz 15, A-8036, Graz, Österreich

    Univ.-Ass. Dr. Marianne Schmid & Univ.-Prof. Dr. Hellmut Samonigg

Authors
  1. Univ.-Ass. Dr. Marianne Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Univ.-Prof. Dr. Hellmut Samonigg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Abteilung für Onkologie, Univ.-Klinik für Innere Medizin I Allgemeines Krankenhaus, Wien, Österreich

    Christoph Zielinski

  2. Klinische Abteilung für Allgemeinchirurgie, Univ.-Klinik für Chirurgie Allgemeines Krankenhaus, Wien, Österreich

    Raimund Jakesz

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Schmid, M., Samonigg, H. (1999). Nachsorge des Mammacarcinoms. In: Zielinski, C., Jakesz, R. (eds) Mammacarcinom. Onkologie heute. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6402-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6402-0_6

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83168-7

  • Online ISBN: 978-3-7091-6402-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation